Works matching Antianxiety drugs


Results: 91
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Discovery of 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3 R)-3-piperidinyl]-1 H-benzimidazole: Integrated Drug-Design and Structure–Activity Relationships for Orally Potent, Metabolically Stable and Potential-Risk Reduced Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist as Antianxiety Drug

    Published in:
    Chemical Biology & Drug Design, 2009, v. 74, n. 4, p. 369, doi. 10.1111/j.1747-0285.2009.00872.x
    By:
    • Hayashi, Shigeo;
    • Hirao, Akiko;
    • Nakamura, Hiroshi;
    • Yamamura, Kenzo;
    • Mizuno, Kunihiko;
    • Yamashita, Hiroyo
    Publication type:
    Article
    11
    12
    14
    15

    The use of antianxiety drugs.

    Published in:
    Clinical Pharmacology & Therapeutics, 1981, v. 29, n. 3, p. 291, doi. 10.1038/clpt.1981.38
    By:
    • Berger, Frank M
    Publication type:
    Article
    16
    17
    18
    19

    Evidence-based clinical practice guidelines for functional dyspepsia.

    Published in:
    Journal of Gastroenterology, 2015, v. 50, n. 2, p. 125, doi. 10.1007/s00535-014-1022-3
    By:
    • Miwa, Hiroto;
    • Kusano, Motoyasu;
    • Arisawa, Tomiyasu;
    • Oshima, Tadayuki;
    • Kato, Mototsugu;
    • Joh, Takashi;
    • Suzuki, Hidekazu;
    • Tominaga, Kazunari;
    • Nakada, Koji;
    • Nagahara, Akihito;
    • Futagami, Seiji;
    • Manabe, Noriaki;
    • Inui, Akio;
    • Haruma, Ken;
    • Higuchi, Kazuhide;
    • Yakabi, Koji;
    • Hongo, Michio;
    • Uemura, Naomi;
    • Kinoshita, Yoshikazu;
    • Sugano, Kentaro
    Publication type:
    Article
    20

    Evidence-based clinical practice guidelines for functional dyspepsia 2021.

    Published in:
    Journal of Gastroenterology, 2022, v. 57, n. 2, p. 47, doi. 10.1007/s00535-021-01843-7
    By:
    • Miwa, Hiroto;
    • Nagahara, Akihito;
    • Asakawa, Akihiro;
    • Arai, Makoto;
    • Oshima, Tadayuki;
    • Kasugai, Kunio;
    • Kamada, Kazuhiro;
    • Suzuki, Hidekazu;
    • Tanaka, Fumio;
    • Tominaga, Kazunari;
    • Futagami, Seiji;
    • Hojo, Mariko;
    • Mihara, Hiroshi;
    • Higuchi, Kazuhide;
    • Kusano, Motoyasu;
    • Arisawa, Tomiyasu;
    • Kato, Mototsugu;
    • Joh, Takashi;
    • Mochida, Satoshi;
    • Enomoto, Nobuyuki
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Polypharmacy of Schizophrenia.

    Published in:
    Psychiatry (1550-5952), 2010, v. 7, n. 8, p. 17
    By:
    • Dussia, Peter;
    • Kalali, Amir H.;
    • Citrome, Leslie
    Publication type:
    Article
    40
    41

    Antianxiety Inclusion.

    Published in:
    JAMA: Journal of the American Medical Association, 2005, v. 294, n. 6, p. 673, doi. 10.1001/jama.294.6.673-c
    By:
    • Kuehn, Bridget M.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Generalized Anxiety Disorder.

    Published in:
    JAMA: Journal of the American Medical Association, 2011, v. 305, n. 5, p. 522, doi. 10.1001/jama.305.5.522
    By:
    • Torpy, Janet M.
    Publication type:
    Article